High-grade serous ovarian carcinoma organoids as models of chromosomal instability

Maria Vias, Lena Morrill Gavarró, Carolin M. Sauer, Debbie Sanders, Anna M. Piskorz, Dominique-Laurent Couturier, Stéphane Ballereau, Bárbara Hernando, James Hall, Filipe Correia-Martins, Florian Markowetz, Geoff Macintyre, James D. Brenton
2022 · doi:10.1101/2022.09.01.506155
preprint OA: gold CC-BY-NC-ND-4.0
📄 Open PDF View at publisher

Abstract

High-grade serous ovarian carcinoma (HGSOC) is the most genomically complex cancer, characterised by ubiquitous TP53 mutation, profound chromosomal instability and heterogeneity. The mutational processes driving chromosomal instability in HGSOC can be distinguished by specific copy number signatures. To develop clinically relevant models of these mutational processes we derived 15 continuous HGSOC patient-derived organoids (PDOs). We carried out detailed bulk transcriptomic, bulk genomic, single cell genomic, and drug sensitivity characterisation of the organoids. We show that PDOs comprise communities of different clonal populations and represent models of different causes of chromosomal instability including homologous recombination deficiency, chromothripsis, tandem-duplicator phenotype and whole genome duplication. We also show that these PDOs can be used as exploratory tools to study transcriptional effects of copy number alterations as well as compound-sensitivity tests. In summary, HGSOC PDO cultures provide a genomic tool for studies of specific mutational processes and precision therapeutics.

My notes (saved in your browser only)

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (1)

References (38)

Source provenance

crossref
last seen: 2026-07-10T06:41:20.800760+00:00
europepmc
last seen: 2026-05-19T01:45:01.086888+00:00
unpaywall
last seen: 2026-05-21T02:00:01.467718+00:00
License: CC-BY-NC-ND-4.0